◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Nova Leap Health Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 8.3M 8.0M 7.1M 6.6M 6.4M --
Operating Revenue 8.3M 8.0M 7.1M 6.6M 6.4M --
Cost Of Revenue 5.0M 4.8M 4.3M 4.0M 4.0M --
Gross Profit 3.3M 3.2M 2.8M 2.6M 2.4M --
Selling General And Administration 2.6M 2.7M 2.5M 2.2M 2.1M --
General And Administrative Expense 2.6M 2.7M 2.5M 2.2M 2.1M --
Depreciation And Amortization In Income Statement 233,427 208,890 196,753 148,358 146,169 --
Other Operating Expenses -- -- -- -- 1.5M 1.5M
Operating Expense 2.9M 2.9M 2.7M 2.4M 2.2M --
Operating Income 418,553 350,439 75,152 221,184 208,110 --
EBIT 670,622 -471,869 4,586 1.1M -129,539 --
Interest Expense 83,750 106,632 81,102 45,242 18,419 --
Interest Expense Non Operating 83,750 106,632 81,102 45,242 18,419 --
Net Interest Income -83,750 -106,632 -81,102 -45,242 -18,419 --
Other Income Expense 252,069 -822,308 -70,566 905,114 -337,649 --
Other Non Operating Income Expenses -- 4,873 -4,873 -6,600 -6,497 -6,195
Special Income Charges -43,145 -27,435 -48,986 -86,266 -116,247 --
Restructuring And Mergern Acquisition 43,145 27,435 48,986 86,266 116,247 --
Write Off -- -- -- -- 0.00 --
Gain On Sale Of Security 295,214 -799,746 -16,707 997,980 -214,905 --
Pretax Income 586,872 -578,501 -76,516 1.1M -147,958 --
Tax Provision 160,701 -94,493 1,783 194,788 59,913 --
Tax Effect Of Unusual Items 69,023 -135,113 -9,854 164,275 -49,673 --
Net Income From Continuing And Discontinued Operation 426,171 -484,008 -78,299 886,268 -207,871 --
Net Income From Continuing Operation Net Minority Interest 426,171 -484,008 -78,299 886,268 -207,871 --
Net Income Including Noncontrolling Interests 426,171 -484,008 -78,299 886,268 -207,871 --
Net Income Common Stockholders 426,171 -484,008 -78,299 886,268 -207,871 --
Net Income 426,171 -484,008 -78,299 886,268 -207,871 --
EBITDA 904,049 -262,979 201,339 1.3M 16,630 --
Normalized EBITDA 651,980 564,202 267,032 362,942 347,782 --
Reconciled Depreciation 233,427 208,890 196,753 148,358 146,169 --
Basic EPS 0.01 -0.01 -0.00 -- -0.00 0.00
Diluted EPS 0.01 -0.01 -0.00 -- -0.00 0.00
Basic Average Shares 87.3M 87.3M 87.3M -- 86.2M 87.5M
Diluted Average Shares 88.0M 87.3M 87.3M -- 87.5M 87.5M
Total Unusual Items 252,069 -827,181 -65,693 911,714 -331,152 --
Total Unusual Items Excluding Goodwill 252,069 -827,181 -65,693 911,714 -331,152 --
Tax Rate For Calcs 0.27 0.16 0.15 0.18 0.15 --
Normalized Income 243,125 208,060 -22,460 138,829 73,608 --
Depreciation Amortization Depletion Income Statement 233,427 208,890 196,753 148,358 146,169 --
Diluted NI Availto Com Stockholders 426,171 -484,008 -78,299 886,268 -207,871 --
Impairment Of Capital Assets -- -- -- -- -- 0.00
Net Income Continuous Operations 426,171 -484,008 -78,299 886,268 -207,871 --
Net Non Operating Interest Income Expense -83,750 -106,632 -81,102 -45,242 -18,419 --
Other Gand A 2.6M 2.6M 2.5M 2.2M 2.1M --
Other Special Charges -- -- -- 0.00 -- --
Reconciled Cost Of Revenue 5.0M 4.8M 4.3M 4.0M 4.0M --
Salaries And Wages 18,726 18,578 17,155 43,405 24,837 --
Total Expenses 7.8M 7.7M 7.0M 6.4M 6.2M --
Total Operating Income As Reported 418,553 350,439 75,152 221,184 208,110 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 1.6M 1.4M 1.3M 1.4M 1.4M --
Cash Cash Equivalents And Short Term Investments 1.6M 1.4M 1.3M 1.4M 1.4M --
Accounts Receivable 2.0M 1.7M 1.7M 1.7M 1.7M --
Receivables 2.0M 1.7M 1.7M 1.7M 1.7M --
Prepaid Assets 277,261 326,508 309,003 319,057 297,580 --
Current Assets 3.8M 3.4M 3.4M 3.4M 3.3M --
Gross PPE -- -- -- 976,560 -- --
Net PPE 789,586 933,930 945,607 976,560 990,968 --
Goodwill 17.0M 17.1M 16.7M 16.0M 14.8M --
Goodwill And Other Intangible Assets 17.7M 17.9M 17.5M 16.6M 15.2M --
Other Intangible Assets 654,655 784,358 773,002 634,209 429,173 --
Total Non Current Assets 19.8M 20.2M 19.8M 19.0M 17.7M --
Total Assets 23.6M 23.6M 23.2M 22.4M 21.0M --
Current Debt 2.0M 2.1M 2.2M 1.3M 147,884 --
Current Debt And Capital Lease Obligation 2.3M 2.4M 2.5M 1.6M 433,769 --
Accounts Payable 1.8M 1.6M 1.6M 1.6M 1.4M --
Payables 1.8M 1.7M 1.6M 1.6M 1.5M --
Payables And Accrued Expenses 1.8M 1.7M 1.6M 1.6M 1.5M --
Current Liabilities 4.1M 4.1M 4.1M 3.2M 1.9M --
Long Term Debt 209,492 204,384 225,516 218,575 24,707 --
Long Term Debt And Capital Lease Obligation 740,087 828,028 857,977 903,447 754,282 --
Long Term Capital Lease Obligation 530,595 623,644 632,461 684,872 729,575 --
Total Non Current Liabilities Net Minority Interest 740,087 828,028 857,977 903,447 754,282 --
Total Liabilities Net Minority Interest 4.8M 4.9M 5.0M 4.1M 2.7M --
Common Stock 19.1M 19.1M 19.1M 19.1M 19.0M --
Capital Stock 19.1M 19.1M 19.1M 19.1M 19.0M --
Additional Paid In Capital 2.4M 2.3M 2.3M 2.3M 2.3M --
Retained Earnings -1.0M -1.4M -947,294 -868,995 -1.8M --
Gains Losses Not Affecting Retained Earnings -1.7M -1.4M -2.3M -2.3M -1.1M --
Other Equity Adjustments -1.7M -1.4M -2.3M -2.3M -1.1M --
Common Stock Equity 18.8M 18.7M 18.2M 18.2M 18.4M --
Stockholders Equity 18.8M 18.7M 18.2M 18.2M 18.4M --
Total Equity Gross Minority Interest 18.8M 18.7M 18.2M 18.2M 18.4M --
Total Capitalization 19.0M 18.9M 18.4M 18.5M 18.4M --
Net Tangible Assets 1.1M 808,598 687,815 1.6M 3.2M --
Tangible Book Value 1.1M 808,598 687,815 1.6M 3.2M --
Working Capital -274,641 -728,838 -757,584 183,817 1.4M --
Invested Capital 21.0M 21.0M 20.6M 19.8M 18.6M --
Total Debt 3.0M 3.3M 3.3M 2.5M 1.2M --
Net Debt 636,761 931,652 1.1M 138,633 -- --
Share Issued 87.3M 87.3M 87.3M 87.3M 86.2M --
Ordinary Shares Number 87.3M 87.3M 87.3M 87.3M 86.2M --
Capital Lease Obligations 802,293 944,072 946,334 984,555 1.0M --
Current Capital Lease Obligation 271,698 320,428 313,873 299,683 285,885 --
Leases -- -- -- 941,185 -- --
Machinery Furniture Equipment -- -- -- 35,375 -- --
Non Current Deferred Assets 1.3M 1.4M 1.4M 1.4M 1.5M --
Non Current Deferred Taxes Assets 1.3M 1.4M 1.4M 1.4M 1.5M --
Other Current Borrowings 2.0M 2.1M 2.2M 1.3M 147,884 --
Other Payable 41,922 45,521 42,330 49,804 45,098 --
Properties -- -- -- 0.00 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow 470,890 611,932 196,758 338,717 287,259 --
Cash Flow From Continuing Operating Activities 470,890 611,932 196,758 338,717 287,259 --
Depreciation And Amortization 233,427 208,890 196,753 148,358 146,169 --
Depreciation Amortization Depletion 233,427 208,890 196,753 148,358 146,169 --
Stock Based Compensation 18,726 18,578 17,155 43,405 24,837 --
Deferred Tax 116,536 -85,368 -45,401 111,577 50,038 --
Deferred Income Tax 116,536 -85,368 -45,401 111,577 50,038 --
Change In Working Capital -105,468 72,722 11,978 111,635 36,401 --
Changes In Account Receivables -320,471 78,275 10,447 -17,717 -159,324 --
Change In Receivables -320,471 78,275 10,447 -17,717 -159,324 --
Change In Payables And Accrued Expense 165,756 11,952 -10,098 150,829 64,729 --
Change In Payable 165,756 11,952 -10,098 150,829 64,729 --
Other Non Cash Items 79,608 94,127 81,102 4,190 19,414 --
Purchase Of PPE -- -- -- -25,000 0.00 0.00
Net PPE Purchase And Sale -- -- -- -25,000 0.00 0.00
Purchase Of Business 0.00 -279,919 -963,015 -1.3M 0.00 --
Investing Cash Flow 0.00 -279,919 -963,015 -1.3M 0.00 --
Cash Flow From Continuing Investing Activities 0.00 -279,919 -963,015 -1.3M 0.00 --
Issuance Of Debt 0.00 0.00 930,145 -- 0.00 0.00
Repayment Of Debt -243,220 -250,322 -191,122 -240,888 -91,772 --
Net Issuance Payments Of Debt -243,220 -250,322 739,023 989,513 -91,772 --
Financing Cash Flow -285,003 -294,172 696,291 1.1M -91,772 --
Cash Flow From Continuing Financing Activities -285,003 -294,172 696,291 1.1M -91,772 --
Effect Of Exchange Rate Changes -7,455 22,328 314.00 -15,733 145.00 --
Changes In Cash 185,887 37,841 -69,966 57,500 195,487 --
Beginning Cash Position 1.4M 1.3M 1.4M 1.4M 1.2M --
End Cash Position 1.6M 1.4M 1.3M 1.4M 1.4M --
Free Cash Flow 470,890 611,932 196,758 313,717 287,259 --
Income Tax Paid Supplemental Data 32,897 52,851 7,381 0.00 0.00 --
Interest Paid Supplemental Data 62,276 59,493 58,409 33,012 15,792 --
Asset Impairment Charge -- -- -- 0.00 0.00 0.00
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00 --
Change In Account Payable 169,355 8,761 -2,624 146,123 67,930 --
Change In Prepaid Assets 49,247 -17,505 11,629 -21,477 130,996 --
Interest Paid Cff -41,783 -43,850 -42,732 -6,538 0.00 --
Long Term Debt Payments -119,926 -126,472 -93,232 -213,106 -91,772 --
Net Business Purchase And Sale 0.00 -279,919 -963,015 -1.3M 0.00 --
Net Foreign Currency Exchange Gain Loss -298,110 786,991 13,470 -996,260 218,271 --
Net Income From Continuing Operations 426,171 -484,008 -78,299 886,268 -207,871 --
Net Long Term Debt Issuance -119,926 -126,472 -93,232 -213,106 -91,772 --
Net Short Term Debt Issuance -123,294 -123,850 832,255 1.2M 0.00 --
Operating Gains Losses -298,110 786,991 13,470 -966,716 218,271 --
Short Term Debt Issuance 0.00 0.00 930,145 -- 0.00 0.00
Short Term Debt Payments -123,294 -123,850 -97,890 -27,782 0.00 --
NEWS
Loading news...
TRENDING
Loading...